検索結果 - Natasa Jávorszky
- 検索結果 1 - 3 結果 / 3
-
1
MicroRNAs Regulate TASK‐1 and Are Linked to Myocardial Dilatation in Atrial Fibrillation 著者: Felix Wiedmann, Manuel Kraft, Stefan M. Kallenberger, Antonius Büscher, A Paasche, Pablo L. Blochberger, Timon Seeger, Natasa Jávorszky, G. Warnecke, Rawa Arif, Jamila Kremer, Matthias Karck, Norbert Frey, Constanze Schmidt
出版事項 2022Artigo -
2
Acute antiarrhythmic effects of SGLT2 inhibitors–dapagliflozin lowers the excitability of atrial cardiomyocytes 著者: A Paasche, Felix Wiedmann, Manuel Kraft, Fitzwilliam Seibertz, V Herlt, Pablo L. Blochberger, Natasa Jávorszky, Moritz Beck, L Weirauch, Timon Seeger, Antje Blank, Walter E. Haefeli, Rawa Arif, Anna L. Meyer, G. Warnecke, Matthias Karck, Niels Voigt, Norbert Frey, Constanze Schmidt
出版事項 2024Artigo -
3
Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy 著者: Felix Wiedmann, Christoph Beyersdorf, Xiao Bo Zhou, Manuel Kraft, A Paasche, Natasa Jávorszky, Susanne Rinné, Henry Sutanto, Antonius Büscher, Kathrin I. Foerster, Antje Blank, Ibrahim El‐Battrawy, Xin Li, Siegfried Lang, U. Tochtermann, Jamila Kremer, Rawa Arif, Matthias Karck, Niels Decher, Gunther van Loon, İbrahim Akın, Martin Borggrefe, Stefan M. Kallenberger, Jordi Heijman, Walter E. Haefeli, Hugo A. Katus, Constanze Schmidt
出版事項 2021Artigo
関連主題
Atrial fibrillation
Cardiology
Electrophysiology
Internal medicine
Medicine
Endocrinology
Sinus rhythm
Anesthesia
Atrial action potential
Biology
Cardiac electrophysiology
Dapagliflozin
Diabetes mellitus
Dofetilide
Downregulation and upregulation
Doxapram
Gene
Genetics
Pharmacology
Potassium channel
Proarrhythmia
Repolarization
Type 2 diabetes
microRNA